rivastigmine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Damier, P; Meyniel, C | 1 |
Clerici, F; Elia, A; Maggiore, L; Mariani, C; Pomati, S; Ratti, PL | 1 |
Butler, S; Byrne, EJ; Daniel, S; Grace, J; McKeith, IG; Shankar, KK; Stevens, T; Waite, J; Walker, Z; Wilkinson, D; Woolford, J | 1 |
1 review(s) available for rivastigmine and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
[Lewy body dementia and Parkinson disease dementia].
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists | 2007 |
1 trial(s) available for rivastigmine and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuroprotective Agents; Parkinsonian Disorders; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2001 |
1 other study(ies) available for rivastigmine and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation.
Topics: Acetylcholine; Aged; Cholinesterase Inhibitors; Disease Progression; Humans; Lewy Body Disease; Male; Parkinsonian Disorders; Phenylcarbamates; Rivastigmine; Time Factors | 2007 |